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Osteoblasts and osteoclasts are well orchestrated through different mechanisms of communication 
during bone remodeling. Previously we found that oste clast-specific disruption of one of the BMP 
receptors, Bmpr1a, results in increased osteoblastic bone formation in mice. We hypothesized that 
BMPR1A signaling in osteoclasts regulates production of either membrane bound proteins or secreted 
molecules that regulated osteoblast differentiation. In our current study, we co-cultured wild type 
osteoblasts with either control osteoclasts or osteoclasts lacking BMPR1A signaling activity. We found 
that loss of Bmpr1a in osteoclasts promoted osteoblast mineralization in vitro. Further, we found that the 
expression of Cx43/Gja1 in the mutant osteoclasts was increased, which encoded for one of the gap 
junction proteins connexin 43/gap junction alpha 1. Knockdown of Gja1 in the mutant osteoclasts for 
Bmpr1a reduced osteoblastic mineralization when co-cultured. Our findings suggest that GJA1 may be 
one of the downstream targets of BMPR1A signaling i osteoclasts that mediates osteoclast-osteoblast 
communication during bone remodeling. 
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Introduction 
Bone remodeling is a dynamic process, which relies on the precise coordination of two principal cells 
within bone tissues: bone-formation activity of osteoblasts and bone-resorption activity of osteoclasts. It 
is well known that osteoblasts control osteoclast differentiation through cell-cell contact or paracrine, by 
expressing a number of factors, such as RANKL [Boyle et al., 2003], interleukin (IL) -1 [Lee et al., 2010] 
and -6 [Yoshitake et al., 2008], and tumor necrosis factor (TNF)-α [Atanga et al., 2011]. However, in the 
past few years, it is gradually recognized that oste clasts do not just perform under the control of 
osteoblasts, they in turn influence osteoblasts as well. There are at least three modes of osteoclast-
osteoblast communication. They can make direct contact, allowing membrane-bound ligands and 









Eph receptors on osteoblasts [Edwards and Mundy, 2008], and family of semaphorins on osteoclasts and 
the corresponding receptors on osteoblasts [Kang and Kumanogoh, 2013]. Osteoclasts can form gap 
junctions allowing passage of small water-soluble molecules between the two cell types [Batra et al., 
2012]. Second, osteoclasts secrete diffusible factors and act on osteoblasts via paracrine, such as 
sphingosine 1-phosphate (S1P) [Ryu et al., 2006], platelet-derived growth factor BB (PDGF BB) [Kubota 
et al., 2002; O'Sullivan et al., 2007], and hepatocyte growth factor (HGF) [Grano et al., 1996]. Third, 
during bone resorption, osteoclasts release growth factors and other molecules from bone matrix, such as 
transforming growth factor-β (TGF-β) [Ota et al., 2013] and insulin-like growth factor-I (IGF-I) [Hayden 
et al., 1995].  
 
Recently, we disrupted Bmpr1a, encoding BMP receptor type IA (BMPR1A), in an osteoclast-specific 
manner using a knock-in Cre mouse line to the cathepsin K locus (Ctsk Cre/+; Bmpr1a flox/flox) [Okamoto et 
al., 2011]. We found that deletion of Bmpr1a in differentiated osteoclasts increased osteoblastic bone 
formation, suggesting that BMP signaling through BMPR1A in osteoclasts negatively regulates osteoblast 
differentiation. However, it is largely unknown how BMP signaling in osteoclasts regulates osteoclast-
osteoblast communication. We hypothesized that BMP signaling mediated by BMPR1A in osteoclasts 
regulates production of either membrane bound proteins or secreted molecules that affects osteoblast 
differentiation. In addition, since Ctsk-Cre-expressing cells were recently found to display markers and 
functional properties consistent with mesenchymal progenitors [Yang et al., 2013], another possibility is 
that the phenotype we observed in Bmpr1a conditional knockout mice is due to disruption of Bmpr1a in 
Ctsk-Cre-expressing mesenchymal progenitors. To test the hypothesis that BMPR1A signaling in 
osteoclasts regulate osteoblast function through communication between two types of cells, and to explore 
the molecular mechanisms, it is necessarily and important to set up an in vitro co-culture system. 
 
Gap junctions are clusters of intercellular channels formed from hexamers of connexins (Cx) that connect 









[Kumar and Gilula, 1996]. In bone, gap junctional intercellular communication (GJIC) mediated by 
connexins plays important roles in regulating signal tr nsduction among different bone cells, thus 
influences development, differentiation, modeling ad remodeling of the bone. Connexin 43 (Cx43), also
known as gap junction alpha-1 protein (GJA1) (encoded by Gja1 gene), is a component of gap junctions. 
It is by far the most broadly and ubiquitously expressed member of the connexin family, being expressed 
in nearly all vital organs that include the brain, heart, bone, lungs, stomach and intestine [Laird, 2006]. 
Among the members of the connexin family, Cx43/GJA1 is the most abundantly expressed in bone cells, 
including pre-osteoblasts, osteoblasts, osteocytes and osteoclasts [Ilvesaro et al., 2000; Yellowley et al., 
2000]. Physical contact of two adjacent cells facilitates the communication between the cells through 
Cx43/GJA1 [Lecanda et al., 2000; Meme et al., 2006]. It is known that Cx43/GJA1 positively regulates 
osteoblast differentiation and bone formation [Minkoff et al., 1999]. Besides, Cx43/GJA1 positively 
regulates osteoclastogenesis and bone resorption [Ransjo et al., 2003; Sternlieb et al., 2012]. Osteoclast-
osteoblast interaction contributes to coupling of bne resorption and formation. However, GJIC between 
osteoclast and osteoblast is largely unknown. 
 
In this study, to understand how BMP signaling in oste clasts influences osteoblast differentiation, we co-
cultured osteoclasts with osteoblasts in vitro and determined the extent of osteoblast mineralization which 
osteoclasts contributed to. We found that osteoclasts deficient for BMPR1A promoted osteoblast 
mineralization through up-regulation of a gap junction protein Cx43/GJA1 in osteoclasts. Our findings 
reveal a novel communication between osteoclasts and osteoblasts, which will further deepen 
understanding of bone biology.Materials & Methods 
Mice 
Generation of Bmpr1a null allele and conditional allele were previously reported [Mishina et al., 2002; 
Mishina et al., 1995]. Mice heterozygous null for Bmpr1a carrying tamoxifen (TM)-inducible Cre fusion 
protein Cre-ERTM under the ubiquitin promoter (No. 008085, The Jackson Laboratory) (Bmpr1a +/-: Ubi-









[Mishina et al., 2002] (Fig. 1A) on a 12-hour light/dark cycle. Mice genotyped Bmpr1a fx/+: Ubi-
CreERTM (+)/(-) were designated as control (cont), and Bmpr1a fx/-: Ubi-CreERTM (+)/(-) within the same 
littermate as mutant (mut). All animal experiments were performed in accordance with the policy and 
federal law of judicious use of vertebrate animals as approved by the Institutional Animal Care and Use
Committee (IACUC) at University of Michigan. 
 
Isolation and culture of osteoclasts 
Control and mutant bone marrow cells were collected from the long bones (i.e. femora and humeri) of 1-
month-old mice within littermates. After culturing overnight in α-MEM containing 10% fetal bovine 
serum (Hyclone) (full medium), non-adherent cells were harvested as bone marrow mononuclear cells 
(BMMCs). Proliferation of BMMCs was stimulated with 20 ng/ml Recombinant Murine Macrophage 
Colony Stimulating Factor (rmM-CSF) (PEPROTECH) for 4 days, followed by another 4 days of 
differentiation culture into osteoclasts using 20 ng/ml M-CSF and 50 ng/ml Recombinant Murine soluble 
Receptor Activator of NF-κB Ligand (rmRANKL) (PEPROTECH) [Yang et al., 2004]. Medium was 
changed every other day. 
 
To determine efficacy of osteoclast formation, cells were differentiated using 20 ng/ml M-CSF and 50 
ng/ml RANKL for 6 days, followed by tartrate-resistan  acid phosphatase (TRAP) staining. The number 
of osteoclasts as well as the number of nuclei per osteoclast were counted. To determine bone resorption 
of osteoclasts, cells were seeded onto OsteoAssay Surface (Corning) and differentiated as stated above f r 
6 days. The resorption area was measured and was normalized by osteoclast number. 
 
TM treatment and evaluation of gene recombination 
Ubi Cre-ERTM activity was induced by administering 100 ng/ml of (Z)-4-hydroxytamoxifen (TM) 
(Sigma-Aldrich) in culture for 4 days [Kamiya et al., 2008]. After TM treatment, cells isolated from 









used as control and mutant cells, respectively. To detect Cre-dependent DNA recombination in Bmpr1a, 
genomic PCR was performed using primers fx1: 5’-GGTTTGGATCTTAACCTTAGG-3’ and fx4: 5’-
TGGCTACAATTTGTCTCATGC-3 [Mishina et al., 2002]. This primer set generates a 180-bp amplicon 
after Cre-dependent recombination, while over 1.5-kb amplicon is generated if no recombination is 
occurred (Fig. 1B) [Mishina et al., 2002]. To quantify deletion of Bmpr1a, genomic real-time quantitative 
PCR was performed using TaqMan Gene Expression Assays (Gapdh: Cat. # 4352932E and Bmpr1a: 
custom designed to detect exon 4, SKU # 4331348) (Fig. 1B). Protein level of P-SMAD1/5/9, 
representing BMP-SMAD signaling pathway, in control and mutant osteoclasts after gene recombination 
was assessed by western blot. Differentiated osteoclasts were stimulated with or without 100 ng/ml 
recombinant human bone morphogenetic protein 2 (rhBMP-2) for 30 min before cell lysis. 
 
Osteoblast mono-culture and co-culture 
Primary calvarial pre-osteoblasts were isolated from 1- to 3-day-old wild-type mice as reported [Liu et al., 
2013]. 5 x 104 cells/well of osteoblasts were seeded in 24-well plate and the medium was changed to 
osteogenic differentiation medium (DM) (full medium containing 10 mM β-glycerophosphate and 50 
µg/ml L-ascorbic acid) the next day. For osteoblast-osteoclast co-culture, 1 x 105 mature osteoclasts per 
well were added into osteoblast culture every 3 days and cultured in DM without M-CSF and RANKL 
(Fig. 1F). For each experiment, osteoclasts isolated from five control or mutant mice were pooled after 
confirmation of efficient Cre-dependent DNA recombination. Each experiment was repeated three times 
using different pooled samples.  
 
Alizarin red staining 
After co-culture for 14 days, cells were stained with 40 mM alizarin red S (Sigma-Aldrich) for 10 min at 
room temperature. The number of alizarin red stained odules was counted. The percentage of nodule 
area was measured using Image J (RRID: SCR_003070). To minimize the effects of subjective bias when 









performed by another researcher in a blinded manner (CS). Then 10% w/v cetylpyridinium chloride 
(CPC) (Sigma-Aldrich) was used to dissolve bound alizarin red S and optical density was measured at 
562 nm. 
 
RNA isolation and quantitative real-time RT-PCR 
After BMMCs were differentiated for 4 days (total 8 days after isolation), osteoclasts were stimulated 
with or without 100 ng/ml recombinant human bone morph genetic protein 2 (rhBMP-2, R&D Systems) 
for 6 hours in full medium (10% serum). Total mRNA was isolated using TRIzol reagent (Life 
Technologies). For quantitative real-time RT-PCR analyses, equal amounts of RNA were reverse-
transcribed using Superscript III first-strand synthesis System (Invitrogen) with oligo (dT) as a primer. 
The resulting cDNA templates were subjected to quantitative PCR using TaqMan probes (Gapdh: 
Mm99999915_g1; Sema4d: Mm00443147_m1; Sema7a: Mm00441361_m1; Efnb2: Mm00438670_m1; 
Efna2: Mm00433011_m1; Acp5: Mm00475698_m1; Pdgfbb: Mm00440677_m1; Hgf: 
Mm01135184_m1; Cthrc1: Mm01163611_m1; Sphk1: Mm00448841_g1; Sphk2: Mm00445021_m1; 
Gja1: Mm01179639_s1) by ABI PRISM 7500 (Applied Biosystems). Data were normalized to Gapdh 
expression using the 2-∆∆Ct method. 
 
Gja1 knockdown assay by adenovirus treatment 
BMMCs were expanded using 20 ng/ml M-CSF for 4 days, nd differentiated using 20 ng/ml M-CSF and 
50 ng/ml RANKL for 2 days. The differentiated osteoclasts were transfected with vehicle control 
(Scrambled shRNA with GFP adenovirus, Ad-GFP-U6-shRNA, Vector Biolabs, Cat. No. 1122N) or 
mouse Gja1 shRNA (Ad-GFP-U6-m-GJA1-shRNA, Vector Biolabs, No. shADV-280777) in serum free 
medium containing M-CSF, RANKL and 200 PFU/cell (multiplicity of infection, MOI) of adenoviral 
vector stock for 3 h. Then the medium was replaced to full medium containing M-CSF and RANKL. 










Western blot analysis 
Cells were lysed in RIPA buffer (20 mM Tris-HCl, 0.1% SDS, 1% Triton X-100, 1% sodium 
deoxycholate) containing protease inhibitor (Roche). The resulting lysates were run on 10% Mini-
PROTEAN® TGXTM Gel (Bio-Rad) and transferred to Amersham Hybond-P membrane (GE Healthcare). 
The following antibodies were used (all are from Cell Signaling Technology): rabbit anti-connexin 43 
(1:500, Cat. No. 3512, RRID: AB_2294590), rabbit ani-pSMAD1/5/9 (1:1000, Cat. No. 13820, RRID: 
AB_2493181), and rabbit anti-GAPDH (1:2000, Cat. No. 2118, RRID: AB_1031003). SuperSignal West 
Femto Chemiluminescent substrate was used to detect anti-connexin 43 and anti-pSMAD1/5/9, and Pico 
Chemiluminescent substrate (Thermo Scientific) was used to detect anti-GAPDH. 
 
Statistical analysis 
All results were expressed as means ± standard deviation of triplicate measurements with all experiments 
independently repeated three times. Unpaired Studen’s t-tests were used to evaluate statistical 
differences. Values of p < 0.05 were considered significant. 
 
Results 
Bmpr1a was efficiently disrupted in osteoclasts 
In differentiated osteoclasts, genomic PCR results showed the appearance of a 180-bp band as well as a 
significant reduction in the intensity of the non-recombination bands (>1500 bp) occurred as early as 2 
days after TM treatment (Fig. 1C). Quantitative genomic real-time PCR results showed a significant 
reduction of exon 4 compared to the same cells cultured without TM (Fig 1D). In control cells (Bmpr1a 
fx/+: Ubi-CreERTM (+)/(-), one floxed allele with one wild type allele, thus the maximum reduction of 
exon 4 is 50% after Cre-induced DNA recombination), we observed 38% and 27% reduction of the levels 
of exon 4 of Bmpr1a in undifferentiated and differentiated osteoclasts, while in mutant cells (Bmpr1a fx/-: 
Ubi-CreERTM (+)/(-), one floxed allele with one null allele), we observed 79% and 89% reduction in 









signal of P-SMAD1/5/9, whereas in mutant osteoclasts, BMP stimulation did not increase P-SMAD1/5/9 
level as observed in control osteoclasts (Fig. 1E, 70% reduction in mutant osteoclasts compared with 
control). Taken together, these results suggested efficient deletion of Bmpr1a in both undifferentiated and 
differentiated osteoclasts by 4 days of TM treatment as evidenced by the significant reduction of BMP-
SMAD signaling activity. 
 
BMPR1A negatively regulated osteoclast formation 
First, we investigated the impact of the loss of BMPR1A signaling during osteoclastogenesis and 
resorption activity using in vitro system. After 6 days of culture in differentiation media, the Bmpr1a 
deficient cells showed higher number of osteoclasts compared with control (2.7-folds, Supplemental Fig. 
S1A). However, mutant osteoclasts were smaller in size with fewer nuclei (Supplemental Fig. S1B). In 
terms of bone resorption function per osteoclast, there was no significant difference between control and
mutant osteoclasts (Supplemental Fig. S1C). These rults suggested that disruption of Bmpr1a in 
osteoclasts increased osteoclast formation, but attenuated further differentiation to fuse together. 
BMPR1A deletion did not influence osteoclast resorpti n activity. 
 
Loss of Bmpr1a in osteoclasts promoted osteoblast mineralization 
Alizarin red staining showed that presence of osteoclasts promoted mineralization of osteoblasts (Fig. 1F, 
and Fig. 2), i.e. co-culture showed higher number of mineralized nodules (1.6 folds and 2.9 folds in 
osteoblasts co-cultured wit  control and mutant oste clasts respectively, compared with osteoblast mono-
culture), and larger area of mineralized nodules (3.1 folds and 8.3 folds in osteoblasts co-cultured with 
control and mutant osteoclasts respectively, compared with osteoblast mono-culture), as well as more 
calcium deposit (16% and 32% increase in osteoblasts co-cultured with control and mutant osteoclasts 
respectively, compared with osteoblast mono-culture), as quantified in Fig. 2B. More importantly, 
osteoclasts with disrupted Bmpr1a further promoted osteoblast mineralization (77% increase in nodule 









mutant osteoclasts compared with osteoblasts co-cultured with control osteoclasts) (Fig. 2). These results 
indicate that co-culture of osteoblasts with osteoclasts positively influences osteoblast mineralization, and 
suggest that BMP signaling through BMPR1A in osteoclasts indirectly, but negatively regulates 
osteoblast mineralization. 
 
Expression of genes mediating osteoclast-osteoblast communication was changed 
Since mutant osteoclasts promoted osteoblast mineralization in the co-culture system, we hypothesized 
that there were changes in mutant osteoclasts in secreted molecules or membrane bound proteins, which 
were involved in osteoclast-osteoblast communication. Based on published information, we selected 11 
genes known to function in osteoclast-osteoblast communication and examined their expression [Batra et 
al., 2012; Edwards and Mundy, 2008; Grano et al., 1996; Kang and Kumanogoh, 2013; Kubota et al., 
2002; O'Sullivan et al., 2007; Ryu et al., 2006; Takeshita et al., 2013]. We found that the expression of 
Cx43/Gja1 was increased in mutant osteoclasts (~4 folds) compared with control osteoclasts in the 
absence or presence of BMP2 (Fig. 3A). The expression of Efna2 was decreased (~30%) in mutant 
osteoclasts compared with control osteoclasts, in addition, 6 h of BMP2 treatment further lowered the 
expression of Efna2 in both control and mutant osteoclasts (23% and 39% decrease in control and mutant 
osteoclasts, respectively, compared with no BMP2 treatment) (Fig. 3B). No overt changes were observed 
in other candidate genes (Fig. 3). EphrinA2 has been shown to mediate crosstalk between osteoclasts and 
osteoblasts [Irie et al., 2009], however, communication through Cx43/GJA1 between those two types of 
cells is largely unknown. T us, we decided to furthe  focus on Cx43/Gja1 in this study. 
 
Knockdown of Cx43/Gja1 in osteoclasts decreased osteoblast mineralization 
To explore a possibility that 6 h treatment was not enough or too long to observe the impact of BMP-2, 
we next examined the expression of Cx43/Gja1 stimulated with BMP2 for different time periods. The 
expression of Cx43/Gja1 decreased in both control and mutant osteoclasts after 6 h of stimulation, i.e., at 









osteoclasts at all time points examine. These results indicate that expression of Cx43/Gja1 in osteoclasts 
was negatively regulated by BMP signaling, at least in part, through type 1A receptor. 
 
To understand the role of Cx43/GJA1 in terms of oste clast-osteoblast communication by knocking down 
Cx43/Gja1 in mutant osteoclasts using adenovirus expressing shRNA. Strong GFP signal was detected 48 
h after transduction that was also encoded by the adenovirus vector used for shRNA expression (Fig 4B). 
The transduction efficiency based on the percentage of GFP positive cells was approximately 80%. 
Quantitative RT-PCR results showed that the expression of Cx43/Gja1 did not change 24 h after 
transduction. At 48 h, 72 h, and 96 h after transduction, the expression of Cx43/Gja1 decreased by ~50%, 
compared with no transduction and scrambled shRNA (Fig. 4C). Cx43/GJA1 protein level revealed a 
33% decrease at 48 h after transduction, an approximate 70% decrease at 72 h and 96 h after transduction 
(Fig. 4D). These results suggested that Cx43/Gja1 was efficiently knocked down, and protein level was 
significantly reduced in the condition we employed. According to the co-culture scheme (Fig. 1F), we 
treated osteoclasts with the adenoviruses 48 h before adding to the co-culture (Fig. 4F). 
 
Consistent with Fig. 2, alizarin red staining in Fig. 5 confirmed that co-cultured osteoblasts with 
osteoclasts enhanced osteoblast mineralization, compared with osteoblast mono-culture (OB only); 
mutant osteoclasts further promoted osteoblast mineral zation (OB + mut OC), compared with control 
osteoclast (OB + cont OC) (Fig. 5). There was no difference between osteoblasts co-cultured with mutant 
osteoclasts (OB + mut OC) and mutant osteoclasts tran duced scrambled shRNA (OB + mut OC sh-Scrb). 
However, after knocking down of Cx43/Gja1 in mutant osteoclasts, the mineralization was significantly 
decreased (OB + mut OC sh-Gja1) compared with osteoclasts transduced scrambled shRNA (OB + mut 
OC sh-Scrb), but still higher than osteoblast mono-culture (OB only) (Fig. 5A and 5B). These results 
suggested that BMP signaling mediated by BMPR1A in osteoclasts, at least in part, negatively regulated 











Our present results demonstrated that osteoclasts deficient for BMPR1A promoted osteoblast 
mineralization in vitro. The expression of Cx43/Gja1 was up-regulated in mutant osteoclasts compared 
with control osteoclasts. Knockdown of Cx43/Gja1 in osteoclasts using shRNA decreased mineralization 
of osteoblasts when co-cultured in vitro. Our findings suggested that connexin 43 (Cx43)/gap junction 
alpha-1 protein (GJA1) encoded by Gja1 gene is one of the downstream targets of BMPR1A signaling in 
osteoclasts which mediates osteoclast-osteoblast communication. 
 
Gap junctions and Cx43/GJA1 play important roles in osteoclasts, including osteoclast formation, 
resorption and communication in the bone multicellular nit in bone remodeling [Ilvesaro and Tuukkanen, 
2003; Ilvesaro et al., 2000; Ransjo et al., 2003]. Cx43/GJA1 positively regulates osteoclastogenesis in 
vivo [Sternlieb et al., 2012]. Blocking of Cx43/GJA1 affects the fusion of larger osteoclasts with four or 
more nuclei [Hobolt-Pedersen et al., 2014]. The connexin mimetic peptide GAP 27, that inhibits GJIC, 
decreases the numbers of TRAP positive osteoclasts and increases the number of apoptotic osteoclasts 
[Ilvesaro et al., 2001]. Gap junction inhibitors AG or oleamide leads to a significant inhibition of 
resorption pits formation on bone slice [Ransjo et al., 2003]. These experimental evidences suggest th 
crucial role of GJIC in conveying stimulating signali g on osteoclast formation, survival and resorptin. 
We previously reported that BMPR1A in osteoclasts negatively regulates osteoclastogenesis and bone 
resorption in vivo [Okamoto et al., 2011]. In vitro results using spleen cells indicates BMPR1A negatively 
regulates osteoclast formation and expression of osteoclast marker genes [Okamoto et al., 2011]. Together 
with the data shown in our current study, these results could be explained by increased Cx43/Gja1 
expression in the Bmpr1a mutant osteoclasts. In our current study, we found consistent results using bone 
marrow mononucleated cells, i.e. disruption of Bmpr1a increased osteoclastogenesis in vitro, reduced 
formation of multinucleated cells, and normal levels of resorption. Further investigation should shed a 










There are evidences showing that gap junctional intercellular communication (GJIC) occurs between 
osteoblast-osteoblast, osteocyte-osteocyte, osteocyte- steoblast, and osteoblast/osteocyte-osteoclast. 
Transmission of soluble molecules via connexin gap junctions between osteoblasts allows propagation of 
specific signals and response to anabolic agents such as PTH [Chung et al., 2006; Lecanda et al., 1998; 
Stains and Civitelli, 2005]. Gap junctions at the tips of osteocyte cell processes respond to changes i  the
mechanical environment through stimuli such as mechani al loading, and transmit these signals through 
the osteocyte network to osteoblasts via gap junctio s [Bonewald, 2011; Grimston et al., 2006; Yellowley 
et al., 2000]. In addition, GJIC plays an important role in osteoblast-osteocyte communication. 
Osteoblast/osteocyte specific Cx43/Gja1 deficient mice have increased bone resorption and TRAP 
positive osteoclasts [Watkins et al., 2011; Zhang et al., 2011]. In vitro studies using Cx43/Gja1 deficient 
MLO-Y4 cells, a cell line mimicking osteocyte characters, reveal an increase in the RANKL/OPG ratio, 
indicating that loss of Cx43/Gja1 in osteocytes promotes osteoclastogenesis [Bivi et al., 2012; Zhang et 
al., 2011]. Bone marrow stromal cells (BMSCs) are shown to communicate with each other and the bone 
lining cells via gap junctions [Dorshkind et al., 1993; Doty, 1981].  
 
However, the knowledge of the functions of GJIC between osteoclasts and other cell types is still naive. 
In our current study, we demonstrated for the firstt me that disruption of Bmpr1a in osteoclasts promoted 
osteoblast mineralization through up-regulation of Cx43/Gja1 in osteoclasts. It is possible to speculate 
that increased Cx43/GJA1 results in increased trafficking of small molecules from osteoclasts to 
osteoblasts through GJIC. Another possibility is that the up-regulation of Cx43/Gja1 alters osteoclast 
functions that secondarily influence osteoblast functio s. Besides its participation in gap junctions and 
hemichannels, Cx43/GJA1 might affect cellular function by interacting with structural molecules (such as 
caveolin-1 and 3 [Giepmans, 2004; Liu et al., 2010], tight junction protein ZO-1 [Giepmans, 2004], N-
cadherin [Dbouk et al., 2009], alpha-catenin [Dbouk et al., 2009], tubuin [Giepmans, 2004]), 
kinase/phosphatase (such as Src, PKA, PKC [Giepmans, 2004]), growth suppression molecule 









molecules (such as Cox-2, Hsp90 and beta-catenin [Dbouk et al., 2009]). The majority of these 
interactions are localized in areas of the cytoplasmic C-terminal tail of Cx43/GJA1, which does not 
participate in channel formation [Dbouk et al., 2009; Giepmans, 2004]. Thus increased expression of 
Cx43/Gja1 may also increase interactions with intracellular molecules in our mutant osteoclasts, which 
secondarily promotes osteoblast mineralization. The system we employed here does not exclude a 
possibility that osteoclasts regulate osteoblast differentiation through secretion factors. It is an interesting 
future effort to understand the mechanisms of how Cx43/GJA1 involves in communication between 
osteoclasts and osteoblasts, especially necessity of direct cell-cell contact. 
 
It is reported that BMP-2 induces expression of Cx43/Gja1 in cardiomyocyte-like cells [Degeorge et al., 
2008; Hou et al., 2013], in an i vitro mesenchymal cell condensation and chondrogenic differentiation 
model [Zhang et al., 2002], and in an embryonal mouse P19 cell line [Bani-Yaghoub et al., 2000]. While, 
in immortalized human granulosa cells, theca cell-drived BMP4 and BMP7 or oocyte-derived BMP15 
down-regulates Cx43/Gja1 expression and decreases GJIC activity [Chang et al., 2014; Chang et al., 
2013]. It is also reported that BMP2, BMP4 and GDF5 can modulate Cx43/Gja1 promoter activity in the 
osteosarcoma cell line ROS17/2.8, including positive and negative regulatory elements within Cx43/Gja1 
locus. Comparison of Cx43/Gja1 promoter sequences from the human vs. mouse showed five regions 
with significant sequence conservation, two of which contained SMAD binding elements in conjunction 
with a BMP response element [Chatterjee et al., 2003]. In our current study, we found that BMP signalig 
mediated by BMPR1A down-regulated Cx43/Gja1 expression in osteoclasts. These evidences suggest 
that BMP signaling differentially regulates Cx43/Gja1 expression in a cell type dependent manner. 
However, more detailed mechanisms need to be further addressed, including whether Cx43/Gja1 is a 
direct downstream target of BMP signaling in osteoclasts, whether aforementioned putative BMP 
responsive elements in the promoter of Cx43/Gja1 are involving in transcriptional regulation of 










In conclusion, our study identified that disruption of Bmpr1a in osteoclasts promoted osteoblast 
mineralization when co-cultured. Up-regulation of gap junction Cx43/Gja1 in mutant osteoclasts is 
responsible for the enhanced osteoblast function. Our findings reveal a novel communication pathway 
between osteoclasts and osteoblasts, which will help in understanding of bone biology. 
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Figure 1. Bmpr1a was efficiently disrupted in undifferentiated and differentiated osteoclasts. (A) 
Breeding was set up between the mice indicated. Bone marrow cells were harvested and Cre activity was 









quantitative genomic PCR for exon 4. (C) BMMCs were differentiated using 20 ng/ml M-CSF and 50 
ng/ml RANKL and treated with TM for different days, followed by DNA extraction. Recombination 
levels were assessed by genomic PCR using primers fx1 and fx4. A 180-bp amplicon indicated Cre-
dependent recombination, whereas an over 1.5-kb amplicon indicated no recombination. (D) BMMCs 
were treated with or without TM for 4 days in the pr sence of M-CSF only (undifferentiated) or 
differentiation medium (M-CSF and RANKL) (differentia ed), followed by DNA extraction. Deletion 
efficiency of Bmpr1a locus was quantified by genomic real-time quantitative PCR. Levels of the presence 
of exon 4 were compared with the same stock of cells that were not treated with TM. (E) Control and 
mutant BMMCs were differentiated using M-CSF and RANKL for 4 days, and Cre activity was induced 
using tamoxifen at the same time. Then cells were stimulated with or without 100 ng/ml BMP-2 for 30 
min, followed by cell lysis. P-SMAD1/5/9 level was detected by Western blot, and GAPDH was used as a 
loading control. (F) The scheme for osteoclast-osteoblast co-culture. BMMCs were expanded using M-
CSF for 4 days and differentiated using M-CSF and RANKL for another 4 days. 1 x 105 osteoclasts/well 
were added to osteoblast culture every 3 days in osteogenic differentiation medium. cont: control, 
genotyped as Bmpr1a fx/+: Ubi-CreERTM (+)/(-); mut: mutant, genotyped as Bmpr1a fx/-: Ubi-CreERTM 
(+)/(-); het: heterozygous; cKO: conditional knockout; bp: base pair; TM: (Z)-4-hydroxytamoxifen; ex: 
exon; BMMC: bone marrow mononuclear cell; OC: osteoclast; OB: osteoblast; *: p<0.05; **: p<0.01. 
 
Figure 2. Mutant osteoclasts deficient for Bmpr1a promoted osteoblast mineralization. (A) After co-
culture for 14 days, cells were fix and stained for alizarin red. Comparison was done in triplicate. (B) The 
number of mineralized nodules was counted. The percentage of nodule area was measured and calculated. 
The staining was dissolved and the optical density was measured. Bar=2mm. cont: control; mut: mutant; 
OC: osteoclast; OB: osteoblast; *: p<0.05; **: p<0.01. 
 
Figure 3. Osteoclastic expression profiles of candidate genes m diating osteoclast-osteoblast 









without BMP-2 for 6 hours followed by RNA extraction. Quantitative RT-PCR was performed. Gene 
expression levels in control osteoclasts without BMP treatment were calculated as 1. cont: control; mut:
mutant; OC: osteoclast; *: p<0.05; **: p<0.01. 
 
Figure 4. Cx43/Gja1 was efficiently knocked down in osteoclasts by adenovirus treatment. (A) BMMCs 
were differentiated using M-CSF and RANKL for 4 days, then cells were stimulated with BMP-2 for 
different periods followed by RNA extraction. The expression of Cx43/Gja1 was evaluated by 
quantitative RT-PCR. (B) Representative images of osteoclasts 48 h after transfection, showing GFP 
signals (lower panel) and the corresponding bright field (upper panel). (C) The expression of Cx43/Gja1 
after transfection. (D) Protein level of Cx43/GJA1 after transfection. (E) The scheme for co-culture when 
osteoclasts were treated with adenovirus. BMMCs were expanded using M-CSF for 4 days and 
differentiated using M-CSF and RANKL for another 4 days. Two days after differentiation, osteoclasts 
were transfected with adenovirus. 1 x 105 osteoclasts/well were added to osteoblast culture every 3 days 
in osteogenic differentiation medium. cont: control; mut: mutant; OC: osteoclast; BF: bright field; GFP: 
green fluorescent protein; Ad: adenovirus; Scrb: scrambled; *: p<0.05; **: p<0.01. 
 
Figure 5. Mutant osteoclasts promoted osteoblast mineralization in the co-culture, and knockdown of 
Cx43/Gja1 in mutant osteoclasts decreased osteoblast mineralization. (A) Cells were stained with alizarin 
red. Comparison was done in triplicate. (B) The number of mineralized nodules was counted. The 
percentage of nodule area was measured and calculated. The staining was dissolved and the optical 
density was measured. cont: control; mut: mutant; OC: osteoclast; OB: osteoblast; Ad: adenovirus; Scrb: 
scrambled; *: p<0.05; **: p<0.01. 
 
Supplemental Figure S1. In vitro osteoclastogenesis was increased with fewer number of nuclei, but 
resorption was not changed. Bone marrow mononucleated cells (BMMCs) were differentiated with M-









less than 3 nuclei was counted as osteoclasts. (B) The number of nuclei per osteoclast was counted. (C) 
BMMCs were differentiated on a hydroxyapatite-coated well to examine resorption function of 
osteoclasts. The area of resorption as well as the number of TRAP-positive osteoclasts were measured and 




























































Suppl Fig S1-01 . 
 
